Simple Science

Cutting edge science explained simply

# Health Sciences# Neurology

Predicting Vision Loss in Multiple Sclerosis Patients

Research aims to predict vision problems in MS patients using health data.

― 6 min read


MS and Vision LossMS and Vision LossPredictionsvision issues in MS patients.Study reveals methods to anticipate
Table of Contents

Multiple sclerosis (MS) is a disease that affects the nervous system. It usually occurs in people under 50 years old. In MS, the protective covering of nerves in the central nervous system gets damaged. This leads to different symptoms. Patients may feel numbness, tingling, muscle weakness, problems with balance, and sometimes lose control over their bladder.

One common sign of MS is a problem with vision. Many people with MS experience vision issues that may start suddenly. This can include a reduction in how well they see or a painful condition called optic neuritis, where vision worsens over a week or so. Research shows that about a fifth of people with MS might first notice problems with their vision. Throughout the disease, around half of all MS patients will face Vision Problems at some point.

Even though vision problems are closely linked to MS, the latest guidelines for diagnosing MS do not include checks for damage in the optic nerve, which is where these vision issues often start.

The Need for Better Prediction of Vision Loss

While health experts understand the connection between vision problems and MS, there is not enough information about predicting who might face vision issues after being diagnosed with MS. These vision problems can happen because of previous eye conditions unrelated to MS as well. Such conditions may include inflammation in the eye or thinning of certain parts of the eye, which can happen to anyone, not just those with MS. MS can also lead to difficulties in how the eyes work together, causing double vision or blurred sight. However, these issues don’t show up on the common tests used to measure how severe MS is.

There is not a lot of research that focuses on predicting vision issues specifically related to MS. More recent studies have highlighted that checking how well someone sees could indicate how their MS might progress. New tests, such as optical coherence tomography (OCT) and visual evoked potentials (VEP), show promise in identifying people with worsening MS, even before they notice changes in their vision. However, these tests only check for damage after it has already happened, instead of identifying those who may face vision challenges in the future.

Setting Goals for Research

This study aims to achieve two main goals. The first is to look closely at the characteristics of MS patients who face vision problems both before and after their MS diagnosis. The second goal is to create a model that can identify patients likely to experience vision impairment after being diagnosed with MS. To do this, researchers used a large database of health records, which includes information from over 213 million patients, to train Machine Learning models. These models are tools that help find patterns in data, specifically to Predict which MS patients may face vision issues later on.

Vision problems are known to be a common concern among MS patients, yet they are often not captured accurately in the way we measure the severity of the disease. This lack of data can lead to underestimating how many patients are experiencing vision problems. Many MS patients report that these vision issues can be quite serious and have a direct correlation with the overall severity of their MS symptoms.

Previous studies using machine learning have focused on predicting how severe the MS might get or when symptoms may flare up. For example, some researchers have developed tools to estimate the risk of MS worsening after diagnosis. Still, these tools often use patient information that may not be available in larger health databases.

Understanding the Research Process

To examine the common physical issues faced by MS patients, researchers first identified those who had both MS and vision problems. They gathered information from a large number of patients and found that vision impairment was the most common issue reported.

To prepare the data for analysis, researchers used diagnosis codes to categorize patients with MS and various related problems. They specifically looked for those with vision impairment. A preliminary analysis found over 450,000 patients diagnosed with MS, among which about 70,000 also had vision problems. However, to create the model, researchers removed patients who had vision problems before their MS diagnosis, as this could skew the results.

After careful checks, they narrowed down the patient group to just over 42,000 people who had their first vision loss diagnosis after being diagnosed with MS, along with about 330,000 without any vision problems.

The data collected included a wide variety of information from electronic health records. This ranged from demographic details and medications to laboratory results. However, some important data, like imaging reports or clinical notes that could offer more insight into a patient’s condition, were not available.

Building the Predictive Models

Researchers then used machine learning techniques to build models that could predict which patients might experience vision impairment. They trained different types of models, including logistic regression and neural networks, using the data they had.

They divided the patients into groups based on when data was collected in relation to their MS diagnosis. They created three types of models, with each focusing on different stages of patient data leading up to vision impairment. The main goal was to understand how well these models could predict who would likely face vision issues after their MS diagnosis.

The effectiveness of each model was measured using certain criteria, including their accuracy in predicting outcomes. The results showed that the models based on neural networks performed better overall, especially when looking at the entire history of patients' medical records.

Results from the Research

The study found that while the models could predict some patients might have vision issues, the accuracy was not always high, especially when looking at data taken just at the time of MS diagnosis. However, models trained on complete patient histories were more successful in distinguishing between those who would and would not face vision problems in the future.

Overall, the best results came from using neural networks that assessed the full patient data. These models achieved a high rate of accuracy, indicating that they can offer usable predictions based on historical health records.

The Importance of the Findings

Finding ways to predict vision impairment can lead to better monitoring of patients and more timely treatment. If doctors can identify which MS patients are likely to face vision problems in the future, they can provide more intensive care and potentially improve patient outcomes.

This research highlights the need to consider the whole picture of a patient's health when trying to predict future conditions, especially with a complex disease like MS.

Future Directions

Moving forward, more research is needed to refine these models and explore how they can better integrate with other medical data. There is also a need to look into data from various sources to ensure these models can be used effectively across different healthcare settings.

While this study achieved significant milestones, there is still work to be done to improve the reliability and accuracy of these predictions. Ultimately, finding effective ways to predict vision impairment in MS patients can make a big difference in their quality of life and overall healthcare.

Original Source

Title: Vision Impairment prediction for patients diagnosed with Multiple Sclerosis: Cosmos based model training and evaluation

Abstract: ObjectivesMultiple sclerosis (MS) is a complex autoimmune neurological disorder that frequently impacts vision. One of the most frequent initial presentations of MS is acute vision loss due to optic neuritis, an acute disorder caused by MS involvement with the optic nerve. While vision impairment is often the first sign of MS, it can occur or recur at any time during the patients course. In this study, we aim to develop and evaluate machine learning models to predict vision impairment in patients with MS, both at the time of first MS diagnosis and throughout their course of care. Early awareness and intervention in patients likely to have vision loss can help preserve patient quality of life. Materials and MethodsUsing the Epic Cosmos de-identified electronic health record (EHR) dataset, we queried 213+ million patients to extract our MS cohort. Cases were defined as MS patients with vision impairment or optic neuritis (VI) following their first MS diagnosis, while controls were MS patients without VI. We trained logistic regression (LR), light gradient boosting machine (LGBM), and recurrent neural network (RNN) models to predict future VI in MS patients. The models were evaluated for two distinct clinical tasks: prediction of VI at the time of the first MS diagnosis and prediction of VI at the most recent visit. Similarly, we trained the models on different segments of the patient trajectory including up until the first MS diagnosis (MS-First Diagnosis), or until the most recent visit before developing the outcome (MS-Progress) as well as the combination of both (MS-General). Finally, we trained a survival model with the goal of predicting patient likelihood of vision loss over time. We compared the models performance using AUROC, AUPRC, and Brier scores. ResultsWe extracted a cohort of 377,097 patients with MS, including 42,281 VI cases. Our trained models achieved [~]80% AUROC, with RNN-based models outperforming LGBM and LR (79.6% vs 72.8% and 68.6%, respectively) when considering the full patient trajectory. The MS-General RNN model had the highest AUROC (64.4%) for predicting VI at the first MS diagnosis. The MS-Progress survival model achieved a 75% concordance index on the full trajectory, while the more clinically relevant MS-First Diagnosis model achieved 63.1% at initial diagnosis. Discussion and ConclusionThe MS-Progress and MS-General RNN models performed best in both prediction scenarios. While MS-General achieved the best performance at the time of first MS diagnosis with around 1% AUROC increase compared to the MS-First Diagnosis model, it showed around 1% AUROC decrease on the MS progress scenario. All RNN survival models performed the best when they were trained on data corresponding to the evaluation use-case scenarios. RNN based models showed promising performance that demonstrates that they can be useful clinical tools to predict risk of future VI events in patients with MS. Further development of these models will focus on expanding to predict other comorbidities associated with MS relapse or progression.

Authors: Laila Rasmy, B. Buxton, A. Hassan, N. Shalaby, J. W. Lindsey, J. Lincoln, E. Bernstam, W. Anwar, D. Zhi

Last Update: 2023-11-11 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2023.11.10.23298366

Source PDF: https://www.medrxiv.org/content/10.1101/2023.11.10.23298366.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

Similar Articles